"Kabi" Amex blood component separator - Taiwan Registration 3c1f0cab9eb395e6e0b08bade2683f6b
Access comprehensive regulatory information for "Kabi" Amex blood component separator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3c1f0cab9eb395e6e0b08bade2683f6b and manufactured by FRESENIUS KABI WARRENDALE;; Fresenius Kabi AG. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
3c1f0cab9eb395e6e0b08bade2683f6b
DHA00602204300
Product Details
For details, it is Chinese approved copy of the imitation order
B Hematology, pathology, and genetics
B.9245 Automated hemocytoseparator
Input;; Contract manufacturing
Dates and Status
Jan 17, 2011
Jan 17, 2026

